28 research outputs found
Das Zusammenspiel des Proto-Onkogens c-jun und des Tumorsuppressorgens p53 in der Regulation der Zellproliferation und Apoptose
Igbp1 is part of a positive feedback loop in stem cell factor–dependent, selective mRNAtranslation initiation inhibiting erythroid differentiation
The authors thank Dr Victor de Jager for assistance with the Rosetta
Resolver software; Dr Ivo Touw for many fruitful discussions and
critical reading of the manuscript; Liu Wing for technical assistance;
Drs Peter Seither, Andreas Weith (Boehringer Ingelheim,
Biberach, Germany), Helmuth Dolznig, Thomas Waerner, and
Sandra Pilat (IMP, Vienna, Austria) for mRNA profiling of
erythroblasts, of which the complete data will be published
elsewhere; Dr Bart Aarts (Erasmus MC, Rotterdam, The Netherlands)
for assistance in confocal scanning microscopy; Dr David Brautigan
(University of Virginia, Charlottesville) for anti-Igbp1 antibodies;
Dr Manfred Boehm (National Institutes of Health/National
Heart, Lung, and Blood Institute, Bethesda, MD) for anti-Uhmk1
antibodies; and Ortho-Biotech (Tilburg, The Netherlands) for their
kind gift of Eprex (erythropoietin).Stem cell factor (SCF)–induced activation
of phosphoinositide-3-kinase (PI3K) is required
for transient amplification of the
erythroblast compartment. PI3K stimulates
the activation of mTOR (target of
rapamycin) and subsequent release of
the cap-binding translation initiation factor
4E (eIF4E) from the 4E-binding protein
4EBP, which controls the recruitment of
structured mRNAs to polysomes. Enhanced
expression of eIF4E renders proliferation
of erythroblasts independent of
PI3K. To investigate which mRNAs are
selectively recruited to polysomes, we
compared SCF-dependent gene expression
between total and polysome-bound
mRNA. This identified 111 genes primarily
subject to translational regulation. For
8 of 9 genes studied in more detail, the
SCF-induced polysome recruitment of
transcripts exceeded 5-fold regulation and
was PI3K-dependent and eIF4E-sensitive,
whereas total mRNA was not affected by
signal transduction. One of the targets,
Immunoglobulin binding protein 1 (Igbp1),
is a regulatory subunit of protein phosphatase
2A (Pp2a) sustaining mTOR signaling.
Constitutive expression of Igbp1
impaired erythroid differentiation, maintained
4EBP and p70S6k phosphorylation,
and enhanced polysome recruitment
of multiple eIF4E-sensitive mRNAs.
Thus, PI3K-dependent polysome recruitment
of Igbp1 acts as a positive feedback
mechanism on translation initiation underscoring
the important regulatory role of
selectivemRNArecruitment to polysomes
in the balance between proliferation and
maturation of erythroblasts. (Blood. 2008;
112:2750-2760)peer-reviewe
OCT-4 expression in follicular and luteal phase endometrium: a pilot study
<p>Abstract</p> <p>Background</p> <p>The stem cell marker Octamer-4 (OCT-4) is expressed in human endometrium. Menstrual cycle-dependency of OCT-4 expression has not been investigated to date.</p> <p>Methods</p> <p>In a prospective, single center cohort study of 98 women undergoing hysteroscopy during the follicular (n = 49) and the luteal (n = 40) phases of the menstrual cycle, we obtained endometrial samples. Specimens were investigated for OCT-4 expression on the mRNA and protein levels using reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. Expression of OCT-4 was correlated to menstrual cycle phase.</p> <p>Results</p> <p>Of 89 women sampled, 49 were in the follicular phase and 40 were in the luteal phase. OCT-4 mRNA was detected in all samples. Increased OCT-4 mRNA levels in the follicular and luteal phases was found in 35/49 (71%) and 27/40 (68%) of women, respectively (p = 0.9). Increased expression of OCT-4 protein was identified in 56/89 (63%) samples. Increased expression of OCT-4 protein in the follicular and luteal phases was found in 33/49 (67%) and 23/40 (58%) of women, respectively (p = 0.5).</p> <p>Conclusions</p> <p>On the mRNA and protein levels, OCT-4 is not differentially expressed during the menstrual cycle. Endometrial OCT-4 is not involved in or modulated by hormone-induced cyclical changes of the endometrium.</p
The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells
AbstractSRPK1, the prototype of the serine/arginine family of kinases, has been implicated in the regulation of multiple cellular processes such as pre-mRNA splicing, chromatin structure, nuclear import and germ cell development. SRPK1a is a much less studied isoform of SRPK1 that contains an extended N-terminal domain and so far has only been detected in human testis. In the present study we show that SRPK1 is the predominant isoform in K562 cells, with the ratio of the two isoforms being critical in determining cell fate. Stable overexpression of SRPK1a induces erythroid differentiation of K562 cells. The induction of globin synthesis was accompanied by a marked decrease in proliferation and a significantly reduced clonogenic potential. Small interfering RNA-mediated down-regulation of SRPK1 in K562 cells results similarly in a decrease in proliferative capacity and induction of globin synthesis. A decreased SRPK1/SRPK1a ratio is also observed upon hemin/DMSO-induced differentiation of K562 cells as well as in normal human erythroid progenitor cells. Mass spectrometric analysis of SRPK1a-associated proteins identified multiple classes of RNA-binding proteins including RNA helicases, heterogeneous nuclear ribonucleoproteins, ribosomal proteins, and mRNA-associated proteins. Several of the SRPK1a-copurifying proteins have been previously identified in ribosomal and pre-ribosomal complexes, thereby suggesting that SRPK1a may play an important role in linking ribosomal assembly and/or function to erythroid differentiation in human leukaemic cells
FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1
Erythropoiesis requires tight control of expansion, maturation, and survival of erythroid progenitors. Because activation of phosphatidylinositol-3-kinase (PI3K) is required for erythropoietin/stem cell factor–induced expansion of erythroid progenitors, we examined the role of the PI3K-controlled Forkhead box, class O (FoxO) subfamily of Forkhead transcription factors. FoxO3a expression and nuclear accumulation increased during erythroid differentiation, whereas untimely induction of FoxO3a activity accelerated differentiation of erythroid progenitors to erythrocytes. We identified B cell translocation gene 1 (BTG1)/antiproliferative protein 2 as a FoxO3a target gene in erythroid progenitors. Promoter studies indicated BTG1 as a direct target of FoxO3a. Expression of BTG1 in primary mouse bone marrow cells blocked the outgrowth of erythroid colonies, which required a domain of BTG1 that binds protein arginine methyl transferase 1. During erythroid differentiation, increased arginine methylation coincided with BTG1 expression. Concordantly, inhibition of methyl transferase activity blocked erythroid maturation without affecting expansion of progenitor cells. We propose FoxO3a-controlled expression of BTG1 and subsequent regulation of protein arginine methyl transferase activity as a novel mechanism controlling erythroid expansion and differentiation
The Erythroid Phenotype of EKLF-Null Mice: Defects in Hemoglobin Metabolism and Membrane Stability
Development of red blood cells requires the correct regulation of cellular processes including changes in cell morphology, globin expression and heme synthesis. Transcription factors such as erythroid Krüppel-like factor EKLF (Klf1) play a critical role in erythropoiesis. Mice lacking EKLF die around embryonic day 14 because of defective definitive erythropoiesis, partly caused by a deficit in β-globin expression. To identify additional target genes, we analyzed the phenotype and gene expression profiles of wild-type and EKLF null primary erythroid progenitors that were differentiated synchronously in vitro. We show that EKLF is dispensable for expansion of erythroid progenitors, but required for the last steps of erythroid differentiation. We identify EKLF-dependent genes involved in hemoglobin metabolism and membrane stability. Strikingly, expression of these genes is also EKLF-dependent in primitive, yolk sac-derived, blood cells. Consistent with lack of upregulation of these genes we find previously undetected morphological abnormalities in EKLF-null primitive cells. Our data provide an explanation for the hitherto unexplained severity of the EKLF null phenotype in erythropoiesis